959990-35-3 Usage
Description
2,4-Dichloro-6-methoxy-1,5-naphthyridine is a synthetic heterocyclic organic compound with the molecular formula C10H6Cl2NO. It is characterized by the presence of two chlorine atoms at the 2nd and 4th positions, a methoxy group at the 6th position, and a 1,5-naphthyridine ring structure. 2,4-Dichloro-6-methoxy-1,5-naphthyridine is used as an intermediate in the pharmaceutical industry for the synthesis of various pharmaceuticals and serves as a building block for the production of other organic compounds.
Uses
Used in Pharmaceutical Industry:
2,4-Dichloro-6-methoxy-1,5-naphthyridine is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a versatile building block for the development of new drugs with potential therapeutic applications.
Used in Agriculture as a Herbicide:
In the agricultural industry, 2,4-Dichloro-6-methoxy-1,5-naphthyridine is used as a selective herbicide to control the growth of broadleaf weeds. Classified as a chloroacetanilide herbicide, it is effective in controlling a wide variety of weeds in different crops, thus helping to protect and improve crop yields.
However, it is crucial to handle this chemical with care due to its potential toxicity to aquatic life and the possibility of causing skin and eye irritation if not used properly. Proper safety measures and guidelines should be followed to minimize any adverse effects on the environment and human health.
Check Digit Verification of cas no
The CAS Registry Mumber 959990-35-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,9,9 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 959990-35:
(8*9)+(7*5)+(6*9)+(5*9)+(4*9)+(3*0)+(2*3)+(1*5)=253
253 % 10 = 3
So 959990-35-3 is a valid CAS Registry Number.
959990-35-3Relevant articles and documents
Synthesis and evaluation of naphthyridine compounds as antimalarial agents
Zhu, Shuren,Zhang, Quan,Gudise, Chandrashekar,Meng, Li,Wei, Lai,Smith, Erika,Kong, Yuliang
, p. 6101 - 6106 (2008/09/16)
Primaquine is the drug of choice for the radical cure of Plasmodium vivax malaria, but possesses serious side effects. In this study novel primaquine analogues were designed and synthesized. Lower toxicity was achieved by reducing or eliminating the tendency of forming chemically reactive and toxic intermediates and metabolites. In vitro and in vivo studies found that synthesized compounds were less toxic than the parent compound primaquine, while preserving the desired antimalarial activity. Some of these compounds possess a therapeutic index over 10 times superior to that of the commonly used antimalarial drug chloroquine. These compounds, as well as the underlying design rationale, may find usefulness in the discovery and development of new antimalarial drugs.
